Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmet Dogan

Showing results (271-280 of 371) with videos related to

Pageof 38
Sort By:
Blood Cancer Journal|December 13, 2019
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
JAMA Oncology|May 1, 2018
Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center DisasterOla Landgren, Rachel Zeig-Owens, Orsolya Giricz, et al.
JAMA Oncology|July 19, 2019
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple MyelomaOla Landgren, Jonathan N Hofmann, Charlene M McShane, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2013
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosisBridget Charbonneau, Alice H Wang, Matthew J Maurer, et al.
Gastroenterology|May 2, 2002
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradicationHongxiang Liu, Hongtao Ye, Agnes Ruskone-Fourmestraux, et al.
Cancers|June 21, 2020
A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical DiscoveriesDanilo Fiore, Luca Vincenzo Cappelli, Paul Zumbo, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric studyMingfei Yan, Sameer A Parikh, Michelly K Sampaio De Melo, et al.
Blood|July 3, 2019
CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphomaCraig S Sauter, Brigitte Senechal, Isabelle Rivière, et al.
Annals of Surgery|July 23, 2020
Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate RiskJonas A Nelson, Stefan Dabic, Babak J Mehrara, et al.
The Journal of Pathology|February 1, 2005
MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expressionHongtao Ye, Liping Gong, Hongxiang Liu, et al.
Pageof 38

Showing results (271-280 of 371) with videos related to

Sort By:
Pageof 38
Blood Cancer Journal|December 13, 2019
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
JAMA Oncology|May 1, 2018
Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center DisasterOla Landgren, Rachel Zeig-Owens, Orsolya Giricz, et al.
JAMA Oncology|July 19, 2019
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple MyelomaOla Landgren, Jonathan N Hofmann, Charlene M McShane, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2013
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosisBridget Charbonneau, Alice H Wang, Matthew J Maurer, et al.
Gastroenterology|May 2, 2002
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradicationHongxiang Liu, Hongtao Ye, Agnes Ruskone-Fourmestraux, et al.
Cancers|June 21, 2020
A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical DiscoveriesDanilo Fiore, Luca Vincenzo Cappelli, Paul Zumbo, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric studyMingfei Yan, Sameer A Parikh, Michelly K Sampaio De Melo, et al.
Blood|July 3, 2019
CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphomaCraig S Sauter, Brigitte Senechal, Isabelle Rivière, et al.
Annals of Surgery|July 23, 2020
Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate RiskJonas A Nelson, Stefan Dabic, Babak J Mehrara, et al.
The Journal of Pathology|February 1, 2005
MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expressionHongtao Ye, Liping Gong, Hongxiang Liu, et al.
Pageof 38